Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
AKI Staging (KDIGO)Anion Gap + Delta-DeltaCKD Stage (KDIGO)Creatinine ClearanceElectrolyte & Free WaterFENaFEUreaKFRE — Kidney Failure RiskKt/V DialysisSodium CorrectionUACRUPCRUrea Reduction Ratio (URR) CalculatorUric Acid & FEUAUrinary Anion GapWinter's FormulaeGFR (CKD-EPI)
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

Winter's Formula

Winter's Formula

CO₂ Compensation Index

Quick Rule

The Expected PaCO₂ should roughly match the last two digits of the pH.

Compensation Tuner

Enter serum Bicarbonate to execute acid-base respiratory targeting.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Use

Any patient with confirmed Metabolic Acidosis (HCO₃⁻ < 22 mEq/L, pH < 7.35) who has an ABG available — apply before concluding the disorder is simple.
Determining whether the respiratory system is compensating appropriately, undercompensating, or overcompensating for the metabolic derangement.
Unmasking a superimposed respiratory acid-base disorder in any complex or mixed clinical picture.
Emergency medicine: DKA, lactic acidosis from septic shock, toxic ingestion (methanol, ethylene glycol, salicylates, isoniazid), uraemic acidosis, cardiac arrest.
ICU: ventilated patients — to set a rational PaCO₂ target that mirrors appropriate physiological compensation and avoid iatrogenic respiratory alkalosis or acidosis.
Post-intubation: verify that ventilator settings achieve the PaCO₂ that would be expected if the patient were breathing spontaneously with appropriate compensation.

Clinical Prerequisite

Winter's Formula applies exclusively to Metabolic Acidosis as the primary disorder. The primary disorder must be established first using pH, HCO₃⁻, and PaCO₂ together. Do not apply the formula in metabolic alkalosis, primary respiratory disorders, or without a concurrent ABG — a venous HCO₃⁻ alone is insufficient for interpreting PaCO₂.

Where It Should Not Be Applied

Metabolic Alkalosis: has its own compensation rule (PaCO₂ rises ~0.7 mmHg per 1 mEq/L rise in HCO₃⁻, max ~55 mmHg). Winter's Formula does not apply.
Primary Respiratory Acidosis or Alkalosis: these have separate renal compensation rules (acute and chronic variants).
Paediatric patients < 2 years: compensation physiology differs and paediatric-specific nomograms should be applied.
Chronic respiratory failure with known CO₂ retention: the baseline PaCO₂ is already abnormal and makes interpretation unreliable without a known true baseline.

How it Works

Winter's Formula

Expected PaCO₂ = (1.5 × [HCO₃⁻]) + 8 (± 2 mmHg) HCO₃⁻ in mEq/L (use the measured arterial bicarbonate from the ABG, not the calculated value) Result in mmHg Acceptable range: Expected PaCO₂ ± 2 mmHg

Worked Example

01
Patient: DKA. pH 7.20, PaCO₂ 28 mmHg, HCO₃⁻ 10 mEq/L.
02
Expected PaCO₂ = (1.5 × 10) + 8 = 23 mmHg (range: 21–25 mmHg).
03
Measured PaCO₂ = 28 mmHg — higher than expected range of 21–25 mmHg.
04
Interpretation: Inadequate respiratory compensation → concurrent Respiratory Acidosis. Evaluate for respiratory muscle fatigue, opioids, or evolving pneumonia.
05
Action: Consider airway intervention early. Do not wait for frank respiratory failure — these patients can decompensate rapidly when compensation fails.

Interpretation Table

Measured PaCO₂ = Expected (±2)Appropriate compensation. Pure (simple) Metabolic Acidosis. Treat the underlying cause.
Measured PaCO₂ > ExpectedRespiratory Acidosis superimposed on Metabolic Acidosis. The lungs are not compensating sufficiently — consider COPD, respiratory fatigue, CNS depression, neuromuscular disease, or early respiratory failure.
Measured PaCO₂ < ExpectedRespiratory Alkalosis superimposed on Metabolic Acidosis. Over-breathing beyond what compensation requires — strongly consider salicylate toxicity, sepsis (early), hepatic encephalopathy, or a primary central respiratory drive stimulus.

Physiological Rationale

In metabolic acidosis, the fall in pH is sensed within seconds by peripheral chemoreceptors (carotid and aortic bodies) and within minutes by central medullary chemoreceptors. These drive increased respiratory rate and tidal volume — the clinical pattern known as Kussmaul breathing. By excreting CO₂ (a volatile acid), the respiratory system blunts the pH fall without correcting it fully. Crucially, compensation is never complete: pH in pure metabolic acidosis never fully normalises via respiratory compensation alone. The Henderson-Hasselbalch relationship constrains the degree of CO₂ reduction that can occur before cellular oxygen delivery is impaired. Winters et al. empirically quantified this predictable linear relationship, enabling clinicians to distinguish a single pure disorder from a genuinely complex mixed picture.

Why Compensation is Never Complete

Full normalisation of pH via hyperventilation would require a PaCO₂ that itself causes cerebral vasoconstriction and hypoxia.
Severe hypocapnia impairs oxygen delivery by shifting the oxyhaemoglobin dissociation curve leftward (Bohr effect).
Physiological limits: the respiratory system cannot sustain PaCO₂ below ~10–12 mmHg in adults even under maximal drive.
A fully normalised pH in suspected metabolic acidosis should immediately raise suspicion for a concurrent primary Respiratory Alkalosis.

The Henderson-Hasselbalch Anchor

pH = 6.1 + log([HCO₃⁻] / (0.0307 × PaCO₂)) Compensation reduces PaCO₂ to maintain the HCO₃⁻/PaCO₂ ratio and limit pH drop. The ratio, not the absolute values, determines pH.

Clinical Pearls

The Salicylate Trap

Salicylate toxicity produces a classic mixed disorder: High Anion Gap Metabolic Acidosis (from salicylic acid accumulation and uncoupled oxidative phosphorylation producing lactic and keto acids) combined with a primary Respiratory Alkalosis (salicylates directly stimulate the medullary respiratory centre, independent of pH). The PaCO₂ will be lower than Winter's Formula predicts. Early or mild toxicity may present with pure respiratory alkalosis alone, before the metabolic acidosis becomes evident. A PaCO₂ dramatically below the expected value in any patient with anion gap acidosis should prompt immediate salicylate level measurement.

The DKA Intubation Hazard

DKA patients compensate with Kussmaul breathing to achieve PaCO₂ values of 15–25 mmHg. Upon intubation, if the ventilator is not immediately set to match this compensation (high respiratory rate, adequate tidal volume), the PaCO₂ will rise acutely — even to a 'normal' 40 mmHg — causing a precipitous pH drop that can trigger fatal arrhythmia or cardiovascular collapse. Post-intubation ventilator settings in DKA must target the expected PaCO₂ from Winter's Formula, not a 'normal' PaCO₂.

Sequential Acid-Base Analysis — Full Framework

01
Step 1 — pH: Acidaemia (< 7.35) or Alkalaemia (> 7.45)? If pH 7.35–7.45, a disorder may still be present (compensated or mixed).
02
Step 2 — Primary disorder: Low HCO₃⁻ with low PaCO₂ = Metabolic Acidosis. High PaCO₂ with high HCO₃⁻ = Respiratory Acidosis. Assign the primary disorder to whichever matches the pH direction.
03
Step 3 — Apply Winter's Formula: Is the PaCO₂ appropriate, high, or low for the degree of metabolic acidosis?
04
Step 4 — Anion Gap: Calculate AG = Na⁺ − (Cl⁻ + HCO₃⁻). Normal AG ≈ 8–12 mEq/L. If elevated, HAGMA is confirmed.
05
Step 5 — Delta-Delta Ratio: (AG − 12) / (24 − HCO₃⁻). If > 2: concurrent Metabolic Alkalosis. If < 1: concurrent Non-Anion Gap Metabolic Acidosis (NAGMA). If 1–2: pure HAGMA.
06
Step 6 — Osmolal Gap: If toxic alcohol ingestion suspected, calculate OG = Measured Osm − Calculated Osm. OG > 10 mOsm/kg suggests unmeasured osmoles (methanol, ethylene glycol, isopropanol).
07
Step 7 — Urine Anion Gap (if NAGMA present): UAG = Na⁺ + K⁺ − Cl⁻ (urine). Negative UAG → GI bicarbonate loss (diarrhoea). Positive UAG → Renal tubular acidosis or renal failure.

Mixed Disorder Patterns to Recognise

HAGMA + Respiratory AlkalosisSalicylate toxicity (classic), early sepsis, hepatic failure with lactic acidosis.
HAGMA + Respiratory AcidosisSeptic shock with respiratory muscle fatigue, DKA with pneumonia or COPD, cardiac arrest.
HAGMA + Metabolic AlkalosisDKA with protracted vomiting, lactic acidosis in a patient on diuretics. Delta-Delta > 2.
HAGMA + NAGMAEarly uraemia with concurrent diarrhoea, acetazolamide use in a patient with lactic acidosis. Delta-Delta < 1.
Triple disorderHAGMA + Metabolic Alkalosis + Respiratory Alkalosis: severe liver disease with lactic acidosis and vomiting. Requires full stepwise analysis.

Venous vs Arterial Bicarbonate

Venous HCO₃⁻ (from a standard BMP/CMP) is approximately 1–2 mEq/L higher than arterial HCO₃⁻ due to the CO₂ gradient between venous and arterial blood. Winter's Formula was derived using arterial bicarbonate. Using venous HCO₃⁻ introduces a small error but is generally acceptable for screening. For precise interpretation in critically ill patients, always use the arterial ABG bicarbonate value.

Compensation Onset and Time Course

Respiratory compensation begins within minutes of metabolic acidosis onset via peripheral chemoreceptor stimulation.
Full respiratory compensation (maximal hyperventilation) is established within 12–24 hours.
Winter's Formula assumes full compensation is established — it may overestimate the expected response in very acute metabolic acidosis (< 2–4 hours duration).
Renal compensation (bicarbonate regeneration) in primary Respiratory Acidosis takes 3–5 days — a separate consideration.

Next Steps

Appropriate Compensation — Treat the Underlying Cause

01
DKA: IV insulin infusion, aggressive fluid resuscitation (isotonic saline or balanced crystalloid), potassium replacement before insulin if K⁺ < 3.5 mEq/L.
02
Lactic acidosis (Type A — hypoperfusion): restore oxygen delivery — IV fluids, vasopressors if septic shock, treat infection source. Sodium bicarbonate generally not indicated unless pH < 7.0 with haemodynamic compromise.
03
Uraemic acidosis: arrange dialysis if eGFR < 15 with refractory acidosis or if pH < 7.20.
04
Toxic alcohol ingestion: fomepizole (alcohol dehydrogenase inhibitor) ± emergent haemodialysis for methanol or ethylene glycol. Do not wait for organ damage.
05
NAGMA from diarrhoea: oral or IV bicarbonate replacement, address fluid and electrolyte losses.

Inadequate Compensation (PaCO₂ > Expected) — Respiratory Acidosis Superimposed

01
Assess respiratory mechanics immediately: rate, depth, accessory muscle use, SpO₂.
02
Identify cause: COPD exacerbation, pneumonia, opioid/sedative depression, neuromuscular weakness (myasthenia, Guillain-Barré), aspiration.
03
Consider Non-Invasive Ventilation (BiPAP) early in fatiguing patients — do not wait for frank respiratory failure.
04
If intubating: immediately set respiratory rate and tidal volume to target the expected PaCO₂ from Winter's Formula (e.g., RR 24–30/min for DKA with HCO₃⁻ 10 mEq/L).
05
Avoid targeting "normal" PaCO₂ (35–45 mmHg) on the ventilator in any patient with active metabolic acidosis.

Over-compensation (PaCO₂ < Expected) — Primary Respiratory Alkalosis Present

01
Order immediate salicylate level — do not wait for toxidrome symptoms; early salicylism presents subtly.
02
Assess for sepsis: systemic inflammatory response drives central hyperventilation independently.
03
Evaluate for hepatic encephalopathy: hyperammonaemia stimulates central respiratory drive.
04
Consider CNS pathology: brainstem lesions, meningitis, and increased intracranial pressure can produce central hyperventilation.
05
Anxiety/pain-driven hyperventilation: diagnosis of exclusion. Treat the symptom but rule out organic causes first.

Bicarbonate Therapy — Indications and Cautions

Not routinely indicated in metabolic acidosis — treats the pH but not the underlying cause, and may worsen intracellular acidosis via CO₂ generation.
Reasonable to consider in: pH < 7.0–7.10 with haemodynamic instability, severe NAGMA (diarrhoea, RTA) where bicarbonate is genuinely depleted, salicylate toxicity (urinary alkalinisation traps ionised salicylate in urine).
In DKA: bicarbonate is generally not recommended (JDRF/ADA consensus) as it may paradoxically worsen cerebral acidosis and hypokalaemia.
In lactic acidosis: bicarbonate does not improve haemodynamics or survival in randomised data and may worsen lactate generation by alkalosis-driven glycolysis.
THAM (tromethamine) is a CO₂-neutral buffer alternative occasionally used in ventilated patients where CO₂ generation from bicarbonate would be problematic.

The Evidence

Foundational Evidence

Quantitative displacement of acid-base equilibrium in metabolic acidosis.

Albert MS et al. • Annals of Internal Medicine. 1967;66(2):312–322. The original derivation study. Winters and colleagues systematically measured PaCO₂ in patients with metabolic acidosis of varied aetiologies at steady-state compensation. They observed a consistent linear relationship between serum bicarbonate and PaCO₂, producing the formula: Expected PaCO₂ = (1.5 × HCO₃⁻) + 8 ± 2. This remains one of the most widely validated equations in clinical medicine.

Simple and mixed acid-base disorders: a practical approach.

Narins RG et al. • Medicine (Baltimore). 1980;59(3):161–187. A comprehensive framework for applying compensation rules — including Winter's Formula — to clinical acid-base analysis. Established the stepwise approach to mixed disorders that forms the backbone of modern teaching.

Management of life-threatening acid-base disorders.

Adrogué HJ et al. • New England Journal of Medicine. 1998;338(1):26–34 and 338(2):107–111. Two-part NEJM review defining the clinical limits of compensation, indications for bicarbonate therapy, and the dangers of ventilator mismanagement in metabolic acidosis. Established the physiological basis for why normalising PaCO₂ in DKA post-intubation is hazardous.

A guide for predicting arterial CO₂ tension in metabolic acidosis.

Fulop M. • American Journal of Nephrology. 1997;17(5):421–424. Validated Winter's Formula prospectively across multiple metabolic acidosis aetiologies, confirming the ±2 mmHg acceptable range and its reliability in identifying superimposed respiratory disorders.

Metabolic acidosis: pathophysiology, diagnosis and management.

Kraut JA et al. • Nature Reviews Nephrology. 2010;6(5):274–285. Comprehensive review of metabolic acidosis classification, compensation physiology, and the role of predictive formulas including Winter's. Discusses limitations in acute vs chronic settings and the clinical significance of mixed disorders.

Origins & History

Dr. Robert W. Winters

Robert W. Winters (1923–1989) was a paediatric nephrologist and physiologist at Columbia University College of Physicians and Surgeons. Working in the 1960s when acid-base physiology was undergoing rapid quantitative systematisation, Winters brought a rigorous empirical approach to what had been largely qualitative clinical assessment. His 1967 paper with Albert and Dell transformed the evaluation of metabolic acidosis from pattern recognition into a calculable, falsifiable prediction — enabling clinicians to definitively identify whether a second disorder was present rather than speculating.

Historical Context

The 1960s were a pivotal decade for acid-base medicine. The arterial blood gas machine had become clinically available only years earlier, and pioneers including Winters, Schwartz, Cohen, and Brackett were racing to define the normal compensatory responses to primary acid-base disturbances. Winters' contribution was unique in its focus on metabolic acidosis — the most common primary disorder encountered in acutely ill patients — and in the simplicity and accuracy of the resulting linear formula. Parallel work by Brackett, Cohen, and Schwartz (1965) established the respiratory compensation rules, creating the complete framework of six primary disorders and their expected compensations that remains standard teaching today.

Enduring Relevance

Over 55 years after its derivation, Winter's Formula has never been meaningfully superseded. Multiple prospective validation studies across DKA, sepsis, renal failure, and toxic ingestion cohorts consistently confirm its accuracy within the ±2 mmHg range. It is embedded in every major medical curriculum, emergency medicine guideline, and critical care reference — a testament to the durability of well-derived empirical physiology.

Last Comprehensive Review: 2026

Related Tools

Anion Gap
Urinary Anion Gap
Sodium Correction
Nephrology CalculatorsInternal Medicine CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.

Recent Journal Updates

JAMAJul 21, 2026
Are Psychiatric Medications Really Overprescribed?

Clinical Context

We think this has broad domain relevance to Winter's Formula — PaCO2 Compensation.

Emerging Infectious DiseasesJul 17, 2026
The Formula for Better Health

Clinical Context

We think this might be relevant to the clinical guidance for Winter's Formula — PaCO2 Compensation.

WHO NewsJul 15, 2026
New WHO guidelines: up to 45% of dementia risk could be prevented or delayed

Clinical Context

We think this has broad domain relevance to Winter's Formula — PaCO2 Compensation.